Home › Funds › Douglas Lane & Associates, LLC › MRNA

Douglas Lane & Associates, LLC position in MRNA

MODERNA INC · Health Care

Douglas Lane & Associates, LLC reported holding 1,160,945 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$223.6M, representing 3.00% of its reported portfolio and ranking #3 among its reported holdings. Douglas Lane & Associates, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.16M sh
Reported value held$223.56M
Portfolio Weight3.00%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Douglas Lane & Associates, LLC's MRNA position evolved

Douglas Lane & Associates, LLC first disclosed a stake in MRNA in Q3 2023 at 355,177 shares (US$36.7M). The position peaked in Q3 2026 at 1,160,945 shares, worth US$223.6M. Across 13 filings, Douglas Lane & Associates, LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,160,945 shares valued at US$223.6M — a reduction of -182,534 shares quarter over quarter.. Notable position changes include a 63% increase in Q4 2024 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 355.18K $36.69M New
Q4 2023 336.14K $33.43M Reduce
Q1 2024 393.04K $41.88M Add
Q2 2024 404.20K $48.00M Add
Q3 2024 475.09K $31.75M Add
Q4 2024 773.80K $32.17M Add
Q1 2025 873.52K $24.76M Add
Q2 2025 930.16K $25.66M Add
Q3 2025 1.13M $29.15M Add
Q4 2025 1.29M $38.09M Add
Q1 2026 1.31M $66.62M Add
Q2 2026 1.34M $94.08M Add
Q3 2026 1.16M $223.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 36 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Douglas Lane & Associates, LLC held MRNA?

Douglas Lane & Associates, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Douglas Lane & Associates, LLC's current position in MRNA?

As of Q3 2026, Douglas Lane & Associates, LLC holds 1.16M shares of MRNA (MODERNA INC), valued at $223.56M, representing 3.00% of its reported portfolio and ranking #3.

Has Douglas Lane & Associates, LLC been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Douglas Lane & Associates, LLC reduced its position in MRNA. The position peaked in Q3 2026 at 1.16M shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.